Sign up for your FREE email newsletter  +

New

Small changes would make a big difference, say European pharma representatives

Pharmaceutical industry seeks savings through simplification rather than a radical regulatory overhaul at transatlantic trade talks

Europe | North America | Regulatory

Turkish healthcare system responds to new phase of growth

Rising prosperity is driving an expansion of the healthcare infrastructure in Turkey, allowing manufacturers to move away from traditional generics and into contract manufacturing and R&D as well as export markets

Asia

Biotec Services doubles capacity following 15% growth

Will be expanding operational, packaging and storage facilities

Packaging | Europe | Manufacturing

AstraZeneca reveals designs for new Global R&D Centre and HQ in Cambridge, UK

The company expects to start building the new facility early next year

Design and Build | Europe | R and D

Clinical supply chain for biosimilar studies

Comparative testing to demonstrate efficacy is mandatory for biosimilars, but time to market is key to commercial success. Martin Lamb, Biotec Services, examines areas where supply chain design and management can help reduce the risk of delays in such studies

Regulatory | Biotechnology | Measurement and Analysis

Skuldtech becomes Acobiom

Biomarker specialist changes its name to confirm its shift towards personalised medicine

Europe | R and D

Meeting patient needs but with streamlined processes

The industry faces rising costs for clinical trials on drugs designed to treat ever more complex diseases but with lower returns. Susan Birks reports on what is being done to stem the high failure rates and increase transparency

Regulatory | R and D

Asynt adds PressureSyn high pressure reactor to product range

Suitable for stirred or non-stirred high pressure applications

Europe | Manufacturing

Characterisation of biologics: advances and challenges

The biologics market is expected to outpace that of small molecules over the coming years but their large size and complex structures make biologics generally more difficult to manufacture and characterise. Steve Taylor, AB Sciex, reviews recent advances in their analysis and assay development

R and D | Biotechnology | Measurement and Analysis

AMS Biotechnology announces MagSi-Direct

A magnetic technology for bioseparations and studies of biomolecular interactions

Europe | R and D | Manufacturing

Manufacturing efficiency must match demands

In a rapidly changing global marketplace the pharmaceutical industry will have to improve efficiency levels and raise standards to keep pace with demand from developing economies, says the latest CPhI Pharma Insights report on Pharma Manufacturing

Manufacturing